annual EBITDA:
-$43.92M-$21.07M(-92.17%)Summary
- As of today (May 29, 2025), KNSA annual EBITDA is -$43.92 million, with the most recent change of -$21.07 million (-92.17%) on December 31, 2024.
- During the last 3 years, KNSA annual EBITDA has risen by +$110.36 million (+71.53%).
- KNSA annual EBITDA is now -460.75% below its all-time high of $12.18 million, reached on December 31, 2022.
Performance
KNSA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$13.62M+$32.52M(+172.05%)Summary
- As of today (May 29, 2025), KNSA quarterly EBITDA is $13.62 million, with the most recent change of +$32.52 million (+172.05%) on March 31, 2025.
- Over the past year, KNSA quarterly EBITDA has increased by +$29.69 million (+184.70%).
- KNSA quarterly EBITDA is now -70.97% below its all-time high of $46.91 million, reached on September 30, 2022.
Performance
KNSA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$14.23M+$29.69M(+67.61%)Summary
- As of today (May 29, 2025), KNSA TTM EBITDA is -$14.23 million, with the most recent change of +$29.69 million (+67.61%) on March 31, 2025.
- Over the past year, KNSA TTM EBITDA has increased by +$14.10 million (+49.78%).
- KNSA TTM EBITDA is now -135.22% below its all-time high of $40.40 million, reached on June 30, 2023.
Performance
KNSA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KNSA EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -92.2% | +184.7% | +49.8% |
3 y3 years | +71.5% | +160.1% | +88.9% |
5 y5 years | +73.8% | +147.3% | +89.0% |
KNSA EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -460.8% | +71.5% | -71.0% | +160.1% | -135.2% | +88.9% |
5 y | 5-year | -460.8% | +73.8% | -71.0% | +126.0% | -135.2% | +92.3% |
alltime | all time | -460.8% | +73.8% | -71.0% | +120.3% | -135.2% | +92.3% |
KNSA EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $13.62M(-172.1%) | -$14.23M(-67.6%) |
Dec 2024 | -$43.92M(+92.2%) | -$18.90M(+104.1%) | -$43.92M(+80.0%) |
Sep 2024 | - | -$9.26M(-3058.1%) | -$24.40M(-4.2%) |
Jun 2024 | - | $313.00K(-101.9%) | -$25.47M(-10.1%) |
Mar 2024 | - | -$16.08M(-2688.7%) | -$28.33M(+24.0%) |
Dec 2023 | -$22.86M(-287.7%) | $621.00K(-106.0%) | -$22.86M(+35.8%) |
Sep 2023 | - | -$10.32M(+304.5%) | -$16.83M(-141.6%) |
Jun 2023 | - | -$2.55M(-75.9%) | $40.40M(+66.7%) |
Mar 2023 | - | -$10.60M(-259.4%) | $24.24M(+99.1%) |
Dec 2022 | $12.18M(-107.9%) | $6.65M(-85.8%) | $12.18M(-140.7%) |
Sep 2022 | - | $46.91M(-350.6%) | -$29.94M(-72.0%) |
Jun 2022 | - | -$18.72M(-17.4%) | -$106.85M(-16.5%) |
Mar 2022 | - | -$22.66M(-36.1%) | -$127.97M(-17.1%) |
Dec 2021 | -$154.28M(-0.4%) | -$35.46M(+18.2%) | -$154.28M(-9.9%) |
Sep 2021 | - | -$30.01M(-24.7%) | -$171.15M(-6.8%) |
Jun 2021 | - | -$39.84M(-18.6%) | -$183.71M(+4.9%) |
Mar 2021 | - | -$48.97M(-6.4%) | -$175.14M(+13.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | -$154.96M(-7.7%) | -$52.33M(+22.9%) | -$154.96M(+15.1%) |
Sep 2020 | - | -$42.57M(+36.2%) | -$134.64M(+10.4%) |
Jun 2020 | - | -$31.27M(+8.6%) | -$122.00M(-5.8%) |
Mar 2020 | - | -$28.79M(-10.1%) | -$129.51M(-22.9%) |
Dec 2019 | -$167.90M(+55.6%) | -$32.02M(+7.0%) | -$167.90M(-6.6%) |
Sep 2019 | - | -$29.92M(-22.8%) | -$179.76M(+2.1%) |
Jun 2019 | - | -$38.78M(-42.3%) | -$175.99M(+10.9%) |
Mar 2019 | - | -$67.18M(+53.1%) | -$158.72M(+47.1%) |
Dec 2018 | -$107.87M(+65.0%) | -$43.88M(+67.8%) | -$107.88M(+11.6%) |
Sep 2018 | - | -$26.15M(+21.5%) | -$96.70M(+11.4%) |
Jun 2018 | - | -$21.52M(+31.7%) | -$86.79M(+13.2%) |
Mar 2018 | - | -$16.33M(-50.1%) | -$76.66M(+17.3%) |
Dec 2017 | -$65.37M(+172.6%) | -$32.70M(+101.4%) | -$65.37M(+100.1%) |
Sep 2017 | - | -$16.24M(+42.6%) | -$32.67M(+98.9%) |
Jun 2017 | - | -$11.39M(+125.8%) | -$16.43M(+225.8%) |
Mar 2017 | - | -$5.04M | -$5.04M |
Dec 2016 | -$23.98M | - | - |
FAQ
- What is Kiniksa Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual EBITDA year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Kiniksa Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM EBITDA year-on-year change?
What is Kiniksa Pharmaceuticals annual EBITDA?
The current annual EBITDA of KNSA is -$43.92M
What is the all time high annual EBITDA for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual EBITDA is $12.18M
What is Kiniksa Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, KNSA annual EBITDA has changed by -$21.07M (-92.17%)
What is Kiniksa Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of KNSA is $13.62M
What is the all time high quarterly EBITDA for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly EBITDA is $46.91M
What is Kiniksa Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, KNSA quarterly EBITDA has changed by +$29.69M (+184.70%)
What is Kiniksa Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of KNSA is -$14.23M
What is the all time high TTM EBITDA for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM EBITDA is $40.40M
What is Kiniksa Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, KNSA TTM EBITDA has changed by +$14.10M (+49.78%)